JAK2/STAT3 signaling activates epiregulin-induced cancer-associated fibroblasts, which stimulates the epithelial–mesenchymal transition (EMT) of OSCC cells, which is necessary for migration and invasion (Wang et al., 2019). The gene discussed is JAK2; the disease is cancer.